161 related articles for article (PubMed ID: 25079097)
1. Biomarkers in early breast cancer and beyond: who needs all those tests?
Storz-Pfennig P; Wolf K
Lancet Oncol; 2014 Aug; 15(9):919-20. PubMed ID: 25079097
[No Abstract] [Full Text] [Related]
2. Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?
Crivellari D; Molino A
J Clin Oncol; 2010 Jun; 28(16):e257; author reply e258-9. PubMed ID: 20368536
[No Abstract] [Full Text] [Related]
3. Palliative approaches to the patient with breast cancer.
Bartus CM; Schreiber JS; Kurtzman SH
Surg Oncol Clin N Am; 2004 Jul; 13(3):517-30, ix. PubMed ID: 15236733
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
5. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
[TBL] [Abstract][Full Text] [Related]
7. Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?
Pignol JP; Rakovitch E; Olivotto IA
J Clin Oncol; 2011 Jul; 29(21):2841-3. PubMed ID: 21670459
[No Abstract] [Full Text] [Related]
8. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
[TBL] [Abstract][Full Text] [Related]
9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
10. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study.
Monrigal E; Dauplat J; Gimbergues P; Le Bouedec G; Peyronie M; Achard JL; Chollet P; Mouret-Reynier MA; Nabholtz JM; Pomel C
Eur J Surg Oncol; 2011 Oct; 37(10):864-70. PubMed ID: 21843920
[TBL] [Abstract][Full Text] [Related]
11. Does neoadjuvant/adjuvant chemotherapy change the natural history of classic invasive lobular carcinoma?
Katz A
J Clin Oncol; 2005 Sep; 23(27):6796; author reply 6796-7. PubMed ID: 16170189
[No Abstract] [Full Text] [Related]
12. [Inflammatory breast cancer: clinical course, diagnosis and treatment].
Borisov VI; Chkhikvadze TV
Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065
[TBL] [Abstract][Full Text] [Related]
13. Targeting adjuvant chemotherapy: a good idea that needs to be proven!
Hayes DF
J Clin Oncol; 2012 Apr; 30(12):1264-7. PubMed ID: 22355050
[No Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
15. Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients.
Martelli G; Boracchi P; Orenti A; Lozza L; Maugeri I; Vetrella G; Agresti R
Eur J Surg Oncol; 2014 Jul; 40(7):805-12. PubMed ID: 24768443
[TBL] [Abstract][Full Text] [Related]
16. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.
Zork NM; Komenaka IK; Pennington RE; Bowling MW; Norton LE; Clare SE; Goulet RJ
Ann Surg; 2008 Aug; 248(2):280-5. PubMed ID: 18650639
[TBL] [Abstract][Full Text] [Related]
17. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
18. [Update on current care guidelines. Diagnostics and follow-up of breast cancers].
Duodecim; 2005; 121(1):111-2. PubMed ID: 15714657
[No Abstract] [Full Text] [Related]
19. Personalized treatment of early-stage breast cancer: present concepts and future directions.
Harbeck N; Salem M; Nitz U; Gluz O; Liedtke C
Cancer Treat Rev; 2010 Dec; 36(8):584-94. PubMed ID: 20554119
[TBL] [Abstract][Full Text] [Related]
20. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]